Stay updated on Selpercatinib in RET+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Selpercatinib in RET+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selpercatinib in RET+ NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer’s displayed site revision changes from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T20:49:23.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The LIBRETTO-431 page now shows a 403 Forbidden error, replacing the previous study details and removing associated documents, effectively blocking access to the trial's information.
    Difference
    19%
    Check dated 2026-09-22T22:18:54.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page underwent a revision bump from v3.6.6 to v3.7.0, indicating a platform/template upgrade for the ClinicalTrials.gov page. This update does not modify the study details or displayed data.
    Difference
    0.0%
    Check dated 2026-09-15T20:46:31.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, indicating a minor update to the record. This change does not modify the study text or data presented on the page.
    Difference
    0.0%
    Check dated 2026-09-01T18:24:54.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    A funding note '2019 ( U.S. NIH Grant/Contract )' was added to the study's identifiers, indicating NIH support for the LIBRETTO-431 trial. This broadens the funding attribution in the study record.
    Difference
    0.0%
    Check dated 2026-08-25T19:40:59.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was applied, replacing the previous v3.6.4, indicating a backend or documentation update with no visible changes to the study content.
    Difference
    0.0%
    Check dated 2026-08-11T19:24:13.000Z thumbnail image

Stay in the know with updates to Selpercatinib in RET+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selpercatinib in RET+ NSCLC Clinical Trial page.